Here, we found that NBAT1 was significantly down-regulated in GC tissues and associated with tumor differentiation, tumor stage, and lymph node metastasis, suggesting a clinical pathological role of NBAT1 expression in GC patients. This evidence concerns the gene NBAT1 and gastric cancer.